| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2020NatCo..11.4148A |
| P356 | DOI | 10.1038/S41467-020-17936-5 |
| P932 | PMC publication ID | 7435201 |
| P698 | PubMed publication ID | 32811834 |
| P50 | author | Keith R. Jerome | Q57904630 |
| Pavitra Roychoudhury | Q57904635 | ||
| Daniel Stone | Q61162725 | ||
| Alexander L. Greninger | Q81925135 | ||
| Philippe Duchateau | Q91272169 | ||
| Martine Aubert | Q98564772 | ||
| P2093 | author name string | Daniel E Strongin | |
| Meei-Li Huang | |||
| Roman Galetto | |||
| Negar Makhsous | |||
| Anoria K Haick | |||
| Laurence Stensland | |||
| Alexander Tait | |||
| Harshana S De Silva Feelixge | |||
| Lindsay M Klouser | |||
| Michelle A Loprieno | |||
| P2860 | cites work | NIH Image to ImageJ: 25 years of image analysis | Q23319322 |
| Targeted DNA mutagenesis for the cure of chronic viral infections | Q24620150 | ||
| Herpes simplex virus-2 transmission probability estimates based on quantity of viral shedding | Q28236882 | ||
| CRISPR/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections | Q28552274 | ||
| Characteristics of a human cell line transformed by DNA from human adenovirus type 5 | Q29547863 | ||
| The latent herpes simplex virus type 1 genome copy number in individual neurons is virus strain specific and correlates with reactivation | Q33784836 | ||
| Once-daily valacyclovir to reduce the risk of transmission of genital herpes | Q34287411 | ||
| Genome editing and the next generation of antiviral therapy. | Q34529971 | ||
| In vivo disruption of latent HSV by designer endonuclease therapy | Q34540648 | ||
| Meganuclease-mediated Inhibition of HSV1 Infection in Cultured Cells | Q34757252 | ||
| Self-complementary AAV vectors; advances and applications | Q34804660 | ||
| A5-positive primary sensory neurons are nonpermissive for productive infection with herpes simplex virus 1 in vitro | Q35077500 | ||
| Nuclear sensing of viral DNA, epigenetic regulation of herpes simplex virus infection, and innate immunity | Q35582501 | ||
| Rates of reactivation of latent herpes simplex virus from mouse trigeminal ganglia ex vivo correlate directly with viral load and inversely with number of infiltrating CD8+ T cells | Q35947667 | ||
| Somatosensory neuron types identified by high-coverage single-cell RNA-sequencing and functional heterogeneity | Q36751641 | ||
| Distribution of herpes simplex virus type 1 and varicella zoster virus in ganglia of the human head and neck | Q37435402 | ||
| Impairment in reactivation of a latency associated transcript (LAT)-deficient HSV-2 is not solely dependent on the latent viral load or the number of CD8(+) T cells infiltrating the ganglia | Q37435593 | ||
| In vitro Inactivation of Latent HSV by Targeted Mutagenesis Using an HSV-specific Homing Endonuclease | Q37634060 | ||
| CRISPR Editing Technology in Biological and Biomedical Investigation. | Q38688945 | ||
| A combinational CRISPR/Cas9 gene-editing approach can halt HIV replication and prevent viral escape. | Q38759997 | ||
| Antiviral therapy of persistent viral infection using genome editing | Q38977099 | ||
| Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences | Q39639189 | ||
| Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems | Q40137101 | ||
| A Combinatorial CRISPR-Cas9 Attack on HIV-1 DNA Extinguishes All Infectious Provirus in Infected T Cell Cultures | Q40410004 | ||
| Comparison of herpes simplex virus reactivation in ganglia in vivo and in explants demonstrates quantitative and qualitative differences | Q40967821 | ||
| Diversity amongst trigeminal neurons revealed by high throughput single cell sequencing. | Q42366263 | ||
| Intravaginal administration of herpes simplex virus type 2 to mice leads to infection of several neural and extraneural sites | Q42452335 | ||
| Unbiased classification of sensory neuron types by large-scale single-cell RNA sequencing | Q42775852 | ||
| Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir | Q43877603 | ||
| Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial | Q43886317 | ||
| Spread of herpes simplex virus and distribution of latent infection after intraocular infection of the mouse | Q44779391 | ||
| Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract | Q45066119 | ||
| Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield | Q45747699 | ||
| Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial | Q45832697 | ||
| Autonomic nervous system involvement in experimental genital infection by herpes simplex virus type 2. | Q45835831 | ||
| Targets of herpes simplex virus type 1 infection in a mouse corneal model | Q45861131 | ||
| AAVrh10 gene therapy ameliorates central and peripheral nervous system disease in canine globoid cell leukodystrophy (Krabbe disease). | Q47556407 | ||
| CRISPR/Cas9 and Genome Editing for Viral Disease-Is Resistance Futile? | Q52430698 | ||
| Viral diversity is an obligate consideration in CRISPR/Cas9 designs for targeting the HIV reservoir. | Q55654521 | ||
| Potential Application of the CRISPR/Cas9 System against Herpesvirus Infections | Q59360276 | ||
| Production of dissociated sensory neuron cultures and considerations for their use in studying neuronal function and plasticity | Q60681167 | ||
| Herpesviral lytic gene functions render the viral genome susceptible to novel editing by CRISPR/Cas9 | Q83225630 | ||
| Integrating single-cell transcriptomic data across different conditions, technologies, and species | Q88243551 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 1 | |
| P304 | page(s) | 4148 | |
| P577 | publication date | 2020-08-18 | |
| P1433 | published in | Nature Communications | Q573880 |
| P1476 | title | Gene editing and elimination of latent herpes simplex virus in vivo | |
| P478 | volume | 11 |
Search more.